Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06371729 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DEEP Substrate Mapping Versus Activation Mapping for VT

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Re-verified, no change to tracked fieldsv4
  2. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 8 more changesShow less
    • Primary endpoints: 1 to 2
    • Study sites: 0 to 1
    • Primary and study completion dates: Jul 2027 to Jun 2027
    • Start date changed from estimate of Jul 2024 to Jun 13, 2024
    • Secondary endpoints expanded, about 9 words
    • Publications: details revised at 3 of 3 entries
    • Eligibility criteria shortened, about 1 word
    • Study title shortened, about 3 words
  3. Minor Study title shortened, about 15 wordsv2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Substrate-based DEEP mapping and activation mapping are two of the main techniques used for guiding ventricular tachycardia (VT) ablation. There is no data comparing directly the extent of applicability, procedural results, and the long-term outcomes between the two mapping strategies.This randomized clinical trial aims to test whether activation mapping is superior to DEEP mapping to reduce ventricular tachycardia recurrence. The primary endpoint of the study is to compare recurrence-free survival rate of ventricular tachycardia at 12 months and procedural feasibility of substrate-based DEEP mapping versus activation mapping for VT ablation.
Trial Details
NCT Number NCT06371729
Lead Sponsor IRCCS Ospedale San Raffaele
Conditions
(from sponsor)
Ventricular Tachycardia
Related terms Tachycardia, Ventricular
Enrollment 222 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov